PBM Report Suggests Wider Use of Tools Can Lead to $1 Trillion in Savings

February 24, 2020

A new study by Visante, funded by the Pharmaceutical Care Management Association (PCMA), suggests greater use of PBM tools could lead to some $1 trillion in savings on drug costs over the next decade, Fierce Healthcare reports.

The study was published Wednesday last week.

“As this analysis indicates, with even greater use of PBM tools, we can achieve more market-based savings to further reduce drug costs for every patient,” PCMA President and CEO JC Scott said in a statement.

To read the full report on Fierce Healthcare, click here.

Share This Story!